NASDAQ:PYXS
Pyxis Oncology, Inc. Stock Insider Trading
$4.34
-0.170 (-3.77%)
At Close: May 10, 2024
| Date | Action | Amount | Person | Type |
|---|---|---|---|---|
| Mar 26, 2024 | Buy | 328 710 | Connealy Pamela Ann | Common Stock |
| Mar 26, 2024 | Buy | 1 071 242 | Sullivan Lara | Stock Option (Right to Buy) |
| Mar 26, 2024 | Buy | 35 219 | Flavin John L | Common Stock |
| Mar 26, 2024 | Buy | 35 219 | Cline Darren S | Common Stock |
| Mar 26, 2024 | Buy | 35 219 | Lewis-hall Freda C | Common Stock |
| Mar 26, 2024 | Buy | 38 741 | Dupont Jakob | Common Stock |
| Mar 26, 2024 | Buy | 38 741 | Humphrey Rachel | Common Stock |
| Mar 26, 2024 | Buy | 44 024 | Civik Thomas | Stock Option (Right to Buy) |
| Mar 26, 2024 | Buy | 131 484 | Wadhane Jitendra | Common Stock |
| Mar 12, 2024 | Buy | 69 760 | Palani Santhosh | Stock Option (Right to Buy) |
| Mar 12, 2024 | Buy | 0 | Palani Santhosh | |
| Dec 29, 2023 | Buy | 443 514 | Kobayashi Ken | Stock Option (Right to Buy) |
| Dec 29, 2023 | Buy | 110 878 | Kobayashi Ken | Stock Option (Right to Buy) |
| Nov 29, 2023 | Sell | 36 949 | Connealy Pamela Ann | Common Stock |
| Nov 27, 2023 | Buy | 0 | Kobayashi Ken | |
| Nov 15, 2023 | Buy | 40 000 | Wadhane Jitendra | Common Stock |
| Sep 28, 2023 | Buy | 8 000 | Connealy Pamela Ann | Common Stock |
| Sep 27, 2023 | Buy | 2 500 | Wadhane Jitendra | Common Stock |
| Sep 27, 2023 | Buy | 6 426 | Connealy Pamela Ann | Common Stock |
| Sep 25, 2023 | Buy | 5 000 | Wadhane Jitendra | Common Stock |
| Sep 25, 2023 | Buy | 12 000 | Connealy Pamela Ann | Common Stock |
| Sep 22, 2023 | Buy | 392 461 | Dupont Jakob | Stock Option (Right to Buy) |
| Sep 22, 2023 | Buy | 2 500 | Wadhane Jitendra | Common Stock |
| Sep 22, 2023 | Buy | 5 000 | Connealy Pamela Ann | Common Stock |
| Sep 18, 2023 | Sell | 8 541 | Sullivan Lara | Common Stock |
| Sep 14, 2023 | Sell | 100 | Sullivan Lara | Common Stock |
| Sep 13, 2023 | Sell | 3 000 | Sullivan Lara | Common Stock |
| Sep 13, 2023 | Sell | 184 742 | Sullivan Lara | Common Stock |
| Sep 12, 2023 | Sell | 4 917 | Sullivan Lara | Common Stock |
| Sep 11, 2023 | Sell | 20 000 | Sullivan Lara | Common Stock |
| Sep 07, 2023 | Buy | 187 793 | Connealy Pamela Ann | Common Stock |
| Sep 07, 2023 | Buy | 93 896 | Wadhane Jitendra | Common Stock |
| Sep 07, 2023 | Buy | 469 483 | Sullivan Lara | Common Stock |
| Aug 23, 2023 | Buy | 17 250 | Dupont Jakob | Stock Option (Right to buy) |
| Aug 23, 2023 | Buy | 5 879 | Dupont Jakob | Stock Option (Right to buy) |
| Aug 23, 2023 | Buy | 3 534 | Dupont Jakob | Stock Option (Right to buy) |
| Aug 23, 2023 | Buy | 0 | Dupont Jakob | |
| Mar 24, 2023 | Buy | 703 379 | Sullivan Lara | Common Stock |
| Mar 24, 2023 | Buy | 990 461 | Sullivan Lara | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 61 825 | Sullivan Lara | Stock Option (Right to buy) |
| Mar 24, 2023 | Sell | 61 825 | Sullivan Lara | Stock Option (Right to buy) |
| Mar 24, 2023 | Sell | 990 461 | Sullivan Lara | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 209 803 | Yanchik Connealy Pamela | Common Stock |
| Mar 24, 2023 | Buy | 322 265 | Yanchik Connealy Pamela | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 10 304 | Yanchik Connealy Pamela | Stock Option (Right to buy) |
| Mar 24, 2023 | Sell | 10 304 | Yanchik Connealy Pamela | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 209 803 | Feingold Jay | Common Stock |
| Mar 24, 2023 | Buy | 157 257 | Feingold Jay | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 17 517 | Feingold Jay | Stock Option (Right to buy) |
| Mar 24, 2023 | Sell | 17 517 | Feingold Jay | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 157 257 | Wadhane Jitendra | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 29 393 | Wadhane Jitendra | Common Stock |
| Mar 24, 2023 | Buy | 45 000 | Wadhane Jitendra | Common Stock |
| Mar 24, 2023 | Sell | 157 257 | Wadhane Jitendra | Stock Option (Right to buy) |
| Mar 24, 2023 | Buy | 139 355 | Lewis-hall Freda C | Common Stock |
| Mar 24, 2023 | Buy | 58 064 | Humphrey Rachel | Common Stock |
| Mar 24, 2023 | Buy | 139 355 | Flavin John L | Common Stock |
| Mar 24, 2023 | Buy | 139 355 | Cline Darren S | Common Stock |
| Mar 24, 2023 | Buy | 139 355 | Civik Thomas | Common Stock |
| Mar 17, 2023 | Buy | 1 811 594 | Pfizer Inc | Common Stock, $0.001 par value per share |
| Mar 17, 2023 | Buy | 1 811 594 | Pfizer Inc | Common Stock, $0.001 par value per share |
| Jan 03, 2023 | Buy | 95 684 | Sullivan Lara | Common Stock |
| Jan 03, 2023 | Buy | 53 931 | Feingold Jay | Common Stock |
| Jan 03, 2023 | Buy | 43 493 | Yanchik Connealy Pamela | Common Stock |
| Oct 06, 2022 | Buy | 0 | Pfizer Ventures (us) Llc | Common Stock, $0.001 par value per share |
| Oct 06, 2022 | Buy | 0 | Pfizer Ventures (us) Llc | Common Stock, $0.001 par value per share |
| Aug 11, 2022 | Buy | 236 220 | Humphrey Rachel | Stock Option (Right to Buy) |
| Aug 11, 2022 | Buy | 236 220 | Humphrey Rachel | Stock Option (Right to Buy) |
| Aug 11, 2022 | Buy | 0 | Humphrey Rachel | |
| Aug 11, 2022 | Buy | 0 | Humphrey Rachel | |
| Aug 03, 2022 | Buy | 157 257 | Wadhane Jitendra | Stock Option (Right to buy) |
| Aug 03, 2022 | Buy | 0 | Wadhane Jitendra | Common Stock |
| Apr 26, 2022 | Buy | 0 | Barclays Plc | |
| Apr 25, 2022 | Buy | 0 | Barclays Plc | Common Stock, par value $0.001 per share |
| Apr 25, 2022 | Buy | 0 | Barclays Plc | Common Stock, par value $0.001 per share |
| Apr 21, 2022 | Sell | 1 745 761 | Chin Mark | Common Stock |
| Apr 14, 2022 | Buy | 93 493 | Yanchik Connealy Pamela | Common Stock |
| Apr 14, 2022 | Buy | 115 931 | Feingold Jay | Common Stock |
| Apr 14, 2022 | Buy | 315 273 | Sullivan Lara | Common Stock |
| Mar 31, 2022 | Buy | 66 831 | Flavin John L | Common Stock |
| Mar 31, 2022 | Buy | 306 930 | Feingold Jay | Common Stock |
| Mar 31, 2022 | Buy | 742 574 | Sullivan Lara | Common Stock |
| Mar 31, 2022 | Buy | 66 831 | Civik Thomas | Common Stock |
| Mar 31, 2022 | Buy | 66 831 | Cline Darren S | Common Stock |
| Mar 31, 2022 | Buy | 66 831 | Chin Mark | Common Stock |
| Mar 31, 2022 | Buy | 247 524 | Yanchik Connealy Pamela | Common Stock |
| Mar 31, 2022 | Buy | 66 831 | Lewis-hall Freda C | Common Stock |
| Dec 08, 2021 | Buy | 10 000 | Cline Darren S | Common Stock |
| Dec 06, 2021 | Buy | 52 944 | Yanchik Connealy Pamela | Stock Option (Right to buy) |
| Nov 18, 2021 | Buy | 15 700 | Civik Thomas | Common Stock |
| Oct 13, 2021 | Buy | 312 500 | Chin Mark | Common Stock |
| Oct 13, 2021 | Buy | 1 433 261 | Chin Mark | Common Stock |
| Oct 13, 2021 | Sell | 9 114 109 | Chin Mark | Series B Convertible Preferred Stock |
| Oct 13, 2021 | Buy | 2 388 | Flavin John L | Common Stock |
| Oct 13, 2021 | Sell | 15 190 | Flavin John L | Series B Convertible Preferred Stock |
| Oct 13, 2021 | Buy | 2 742 338 | Bayer World Investments B.v. | Common Stock |
| Oct 13, 2021 | Sell | 6 076 072 | Bayer World Investments B.v. | Series B Convertible Preferred Stock |
| Oct 13, 2021 | Sell | 11 362 462 | Bayer World Investments B.v. | Series A Convertible Preferred Stock |
| Oct 13, 2021 | Buy | 450 000 | Cormorant Asset Management, Lp | Common Stock |
| Oct 13, 2021 | Buy | 668 854 | Cormorant Asset Management, Lp | Common Stock |
| INSIDER POWER |
|---|
| 74.314 |
| Last 100 transactions |
| Buy: 19 454 079 | Sell: 29 809 207 (Shares) |
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 74.314.
In total, the insiders bought 19 454 079 and sold 29 809 207 PYXS shares in the last 100 trades.
